Russia's sovereign wealth fund has filed for registration of Sputnik V in the European Union and expects it to be reviewed in February, the official account promoting the COVID-19 vaccine tweeted on Wednesday.
The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews. (https://bit.ly/39OQZDR)
The vaccine has already been approved in Argentina, Belarus, Serbia and other countries.
Venezuela quake death toll nears 3,000 as rescue effort winds down
Eight injured in New York shooting
Trump appears on National Mall for July 4 speech after storm-related delay
Qatar says all maritime activities will resume immediately
St. Petersburg region port, oil terminal hit in Ukrainian drone attack
